Shares Of Suncor Energy (SU) At New High Than Panhandle Oil And Gas (PHX), Encana (ECA), Enzo Biochem (ENZ)

Suncor Energy Inc. (SU.TO,SU) reported first quarter operating earnings of C$1.793 billion or C$1.22 per common share, higher than the C$1.367 billion or C$0.90 per common share last year. Cash flow from operations was C$2.880 billion or C$1.96 per common share, versus C$2.284 billion or C$1.50 per common share in the prior year. The company notified that these results were led by strong upstream price realizations driven in part by favourable foreign exchange and thrived inland crude pricing. Suncor Energy Inc. (SU), Independent Oil & Gas, is currently trading at $42.69, which burgeoned 2.08%. The stock is trading 1.86% below its 50 days high and 23.23% above its 50 days low. SU has $62698.80 million market capitalization. The stock recorded a trading volume of 6175748 shares as compared to its average volume of 3047.76 million shares. SU’s year to date performance is 23.24%. Investment experts consider it a ‘Buy’ stock.

Panhandle Oil And Gas Inc. (PHX) announced that its fourth quarter net income jumped to $5.72 million or $0.68 per share from $182,621 or $0.02 per share in the same quarter last year. Net cash provided by operating activities thrived 201% to $13.21 million for the 2013 fourth quarter, versus the 2012 fourth quarter. Total revenues for the 2013 fourth quarter were $18.40 million, increasing 67% from $11.04 million for the 2012 quarter. Panhandle Oil and Gas Inc. (PHX), Independent Oil & Gas, is currently trading at $60.43, which soared 5.70%. The stock is trading 1.56% below its 50 days high and 44.02% above its 50 days low. PHX’s price to free cash flow is 52.97%. Company is trading at a P/E multiple of 23.51x with 3.88% monthly volatility. The stock is having 21.90% return on equity and 14.30% return on assets. PHX’s year to date performance is 81.53%.

Canadian energy producer Encana Corp. (ECA.TO,ECA) announced Tuesday a profit in its first quarter, set side by side to a loss last year, benefited by lower one-time charges. Operating earnings walloped analysts’ estimates with a bloom in revenues mainly on strong Canadian operations. Encana stated it earned $116 million or $0.16 per share in the first quarter 2014, as against a loss of $431 million or $0.59 per share in the prior year. The present results included unrealized hedging loss of $203 million and non-operating foreign exchange loss of $194 million. Encana Corporation (ECA), Major Integrated Oil & Gas company, flourished 2.26% in last regular trading to $24.42. The stock is priced with the difference of 25.86% 200-day simple moving average and 6.84% 50-day moving average. With 5655792 of its shares exchanged hands during the day and 1.16 relative volume ratio, market capitalization of Encana Corporation moved to $18097.66 million. The float was recorded 740.54 million compared to 741.10 million outstanding shares. ECA’s monthly performance is 7.48%. We recommend to ‘Hold’ the stock.

Enzo Biochem, Inc. (ENZ) posted third-quarter net loss of $0.5 million or $0.01 per share, narrower than $5.8 million or $0.15 per share in the comparable quarter last year. Two analysts polled by Thomson Reuters possible the company to declare a loss of $0.09 per share. Analysts’ estimates typically exclude special items. Revenues in the most recent third quarter surged 6.1% to $24.0 million from $22.6 million in the prior year quarter. Enzo Biochem Inc. (ENZ), Medical Laboratories & Research, is currently trading at $5.02, which thrived 2.66%. The stock is trading 0.40% below its 52-week high and 156.12% above its 52-week low. ENZ’s return on investment is -52.00%. Company’s 35.30% shares are under accumulation by financial institutions compare to 0.30% by insiders. ENZ’s yearly performance is 131.34%. Trade experts think of it as ‘Hold’ stock.


Andy Weld, CFA, is an editor and equity analyst for The Downtown Leader. If you have a great story idea for Andy Weld, you can write at [ ].